NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Medical Instruments & Supplies · USD

NEXGEL, Inc. (NXGL) Stock Analysis

NEXGEL, Inc. (NXGL) is a Medical Instruments & Supplies stock listed on NASDAQ and quoted in US Dollar.

NXGL

$0.32

−$0.02 (−6.49%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare NXGL with… →

NXGL Key Statistics

As of Sep 4, 2026
Trading
Open
$0.34
Previous Close
$0.34
Day's Range
0.31–0.34
52-Week Range
0.30–2.89
Volume
93.10K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.75
Valuation
Market Cap
$3.09M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.26
EPS (ttm)Profit attributable to each share over the last twelve months.
−0.69
Financials (FY)
Revenue (FY)
$11.42M+31.46%
Net Income (FY)
−$3.00M
Profit marginThe share of revenue left as profit after all costs and taxes.
−51.26%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
9.75M
1-Year Return
−85.78%
Dividend and dates
Earnings Date
November 10, 2026estimated
Avg Volume
770.84K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

NXGL Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−80.31%
2025−63.90%
2024+109.39%
2023+70.40%
2022−52.11%
2021 (partial year)−25.85%

As of September 4, 2026.

NXGL Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$11.42M−$3.00M−26.3%
2024$8.69M−$3.28M−37.8%
2023$4.09M−$3.16M−77.2%
2022$2.05M−$4.75M−231.7%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$11.42M$4.51M−$3.35M−$3.00M−26.3%
2024$8.69M$2.75M−$3.55M−$3.28M−37.8%
2023$4.09M$374.00K−$3.48M−$3.16M−77.2%
2022$2.05M$256.00K−$3.35M−$4.75M−231.7%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

NXGL Valuation vs Medical Instruments & Supplies Median

Median of 55 stocks
MetricNXGLMedical Instruments & Supplies medianvs median
P/S ratio0.263.170.1x the median
Profit margin−51.26%0.85%52.1 pts below

Medians across 55 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values NEXGEL, Inc. (NXGL) at $3.09M. It is classified in the Medical Instruments & Supplies industry, within the Healthcare sector. Headcount on file is 19.

The most recent close on file for NXGL is $0.32, dated September 4, 2026. That is −$0.02 (−6.49%) against the previous close. The 52-week range on file runs from $0.30 to $2.89. The latest close sits 5.67% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $11.42M. That is +31.46% against the prior fiscal year, when revenue was $8.69M. The same year closed with a net loss of $3.00M. Profit margin runs at −51.26%. That is 52.1 percentage points below the Medical Instruments & Supplies median of 0.85%. Earnings per share on a trailing basis come to −0.69.

Across the 4 fiscal years on file, revenue moves from $2.05M in 2022 to $11.42M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. Measured against sales, the shares trade at 0.26 times revenue. On price-to-sales that is 0.1 times the Medical Instruments & Supplies median of 3.17. 55 Medical Instruments & Supplies companies report these metrics, and the medians quoted come from that group.

Beta against the wider market is reported at 0.75. Daily returns over the trailing 4 years annualize to a volatility of 86.32%. The trailing one-year price return is −85.78%. Measured over 3 years, that is −49.89% a year compounded.

Growth & Income

The record shows no dividend for NXGL.

Across the complete calendar years on file, 2024 returned +109.39% and 2025 returned −63.90%. Of the 4 complete calendar years on file, 2 finished higher. So far in 2026 the price is −80.31%.

Peer Comparison

NEXGEL, Inc. (NXGL) operates in the Medical Instruments & Supplies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
NEXGEL, Inc. NXGL $3.09M —
Intuitive Surgical, Inc. ISRG $131.38B 42.4
Becton, Dickinson and Company BDX $50.32B 32.0
Medline Inc. MDLN $49.23B 45.7

The Medical Instruments & Supplies industry average P/E ratio is 35.6x. NEXGEL, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Instruments & Supplies Stocks

ISRG

Intuitive Surgical, Inc.

$131.38B

 BDX

Becton, Dickinson and Company

$50.32B

 MDLN

Medline Inc.

$49.23B

 ALC

Alcon Inc.

$34.08B

 RMD

ResMed Inc.

$32.94B

 WST

West Pharmaceutical Services, Inc.

$23.93B
View all Medical Instruments & Supplies stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About NEXGEL, Inc.

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also develops NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. It serves its customers under Medagel, Kenkoderm and Silly George brand names. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was incorporated in 2009 and is based in Langhorne, Pennsylvania.

Visit website →